IRVINE, Calif.--(BUSINESS WIRE)--TherOx, Inc., a privately held medical device company focused on improved treatment of Acute Myocardial Infarction (AMI), announced it has received U.S. Food and Drug ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Prehospital pulse-dose glucocorticoid treatment in patients with ST-segment elevation myocardial infarction (STEMI) does not reduce the final infarct size at 3 months but may improve acute outcomes ...
Interv Cardiol. 2013;5(3):289-300. The Export catheter was also used in the larger TAPAS trial. [46] This was a single-center randomized trial that recruited 1071 patients. All the patients received ...
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results